These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10820955)

  • 1. Pertussis seroepidemiology in Taipei.
    Chiu TF; Lee CY; Lee PI; Lu CY; Lin HC; Huang LM
    J Formos Med Assoc; 2000 Mar; 99(3):224-8. PubMed ID: 10820955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years.
    Cattaneo LA; Reed GW; Haase DH; Wills MJ; Edwards KM
    J Infect Dis; 1996 May; 173(5):1256-9. PubMed ID: 8627081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants.
    Gonik B; Puder KS; Gonik N; Kruger M
    Infect Dis Obstet Gynecol; 2005 Jun; 13(2):59-61. PubMed ID: 16011994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroepidemiology of B. pertussis infection in Catalonia, Spain.
    Domínguez A; Vidal J; Plans P; Salleras L
    Epidemiol Infect; 2001 Apr; 126(2):205-10. PubMed ID: 11349970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.
    García-Corbeira P; Dal-Ré R; Aguilar L; García-de-Lomas J
    Vaccine; 2000 Apr; 18(21):2173-6. PubMed ID: 10717335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of pertussis in China: need to improve vaccination strategies.
    Xu Y; Wang L; Xu J; Wang X; Wei C; Luo P; Ma X; Hou Q; Wang J
    Hum Vaccin Immunother; 2014; 10(1):192-8. PubMed ID: 24018405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibody to Bordetella pertussis in neonates and prevalence of recent pertussis infection in pregnant women in Catalonia (Spain) in 2003 and 2013.
    Plans P; Álvarez E; de Ory F; Campins M; Payà T; Balfagón P; Godoy P; Caylà J; Carreras R; Cabero L; Domínguez A;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1114-8. PubMed ID: 24871642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of pertussis antibodies among different age groups in Japan.
    Konda T; Kamachi K; Iwaki M; Matsunaga Y
    Vaccine; 2002 Mar; 20(13-14):1711-7. PubMed ID: 11906757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J; Trollfors B; Hedvall G; Taranger J; Zackrisson G
    Scand J Infect Dis; 1995; 27(3):273-7. PubMed ID: 8539553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
    Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
    J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
    Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
    J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece.
    Polyzou A; Pournaras S; Dafni U; Sofianou D; Christeli E; Patrinos S; Tsakris A
    J Clin Lab Anal; 2004; 18(3):211-4. PubMed ID: 15103688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of serum anti-Bordetella pertussis antibody titers among medical staff members.
    Higa F; Haranaga S; Tateyama M; Hibiya K; Yamashiro T; Nakamatsu M; Tomoyose T; Nagahama M; Okamura T; Owan T; Kuda T; Kinjo F; Fujita J
    Jpn J Infect Dis; 2008 Sep; 61(5):371-4. PubMed ID: 18806344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
    Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
    Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
    Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
    Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standardization of an in-house ELISA for pertussis serology and its application in a seroepidemiological study].
    Cöplü N; Esen B; Kurtoğlu D; Gözalan A; Miyamura K; Yoshida I
    Mikrobiyol Bul; 2005 Jul; 39(3):281-9. PubMed ID: 16358487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
    Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
    BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants.
    Ercan TE; Sonmez C; Vural M; Erginoz E; Torunoğlu MA; Perk Y
    Vaccine; 2013 Aug; 31(38):4172-6. PubMed ID: 23845808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.